Your browser is no longer supported. Please, upgrade your browser.
Settings
CRVS Corvus Pharmaceuticals, Inc. daily Stock Chart
CRVS [NASD]
Corvus Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.63 Insider Own5.00% Shs Outstand29.43M Perf Week-0.24%
Market Cap116.86M Forward P/E- EPS next Y-1.54 Insider Trans-52.21% Shs Float23.24M Perf Month-16.25%
Income-48.00M PEG- EPS next Q-0.24 Inst Own75.10% Short Float5.56% Perf Quarter34.30%
Sales- P/S- EPS this Y6.80% Inst Trans- Short Ratio0.63 Perf Half Y-14.08%
Book/sh1.73 P/B2.40 EPS next Y-29.60% ROA-58.10% Target Price- Perf Year16.57%
Cash/sh2.11 P/C1.97 EPS next 5Y- ROE-69.50% 52W Range1.01 - 6.88 Perf YTD-23.71%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-39.68% Beta2.25
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin- 52W Low310.89% ATR0.48
Employees52 Current Ratio5.20 Sales Q/Q- Oper. Margin- RSI (14)52.73 Volatility7.81% 10.41%
OptionableYes Debt/Eq0.00 EPS Q/Q18.60% Profit Margin- Rel Volume0.15 Prev Close4.09
ShortableYes LT Debt/Eq0.00 EarningsJul 30 AMC Payout- Avg Volume2.05M Price4.15
Recom1.60 SMA20-3.72% SMA5013.69% SMA20014.78% Volume305,368 Change1.47%
Sep-12-19Initiated Mizuho Buy
May-29-19Initiated ROTH Capital Buy $6
Aug-24-17Upgrade Credit Suisse Underperform → Neutral
May-01-17Downgrade Credit Suisse Neutral → Underperform
Apr-18-16Initiated Guggenheim Buy
Apr-18-16Initiated Credit Suisse Outperform
Aug-04-20 04:05PM  
Aug-03-20 11:33AM  
Jul-30-20 04:02PM  
Jul-23-20 08:30AM  
Jul-20-20 03:30PM  
Jul-09-20 08:43AM  
Jul-08-20 10:22AM  
09:58AM  
Jul-07-20 09:53AM  
09:32AM  
08:51AM  
07:00AM  
Jul-03-20 06:12PM  
Jun-24-20 08:40AM  
May-29-20 08:00AM  
May-27-20 08:00AM  
May-20-20 12:00PM  
May-13-20 05:23PM  
May-04-20 07:26AM  
Apr-30-20 04:05PM  
Apr-22-20 08:30AM  
Mar-10-20 05:14PM  
Mar-05-20 04:05PM  
Feb-28-20 04:01PM  
Feb-19-20 04:05PM  
Feb-13-20 08:00AM  
Feb-01-20 02:00PM  
Dec-20-19 10:56AM  
Dec-17-19 06:28AM  
Dec-07-19 09:00AM  
Nov-08-19 07:00AM  
Nov-07-19 08:30AM  
Nov-05-19 08:30AM  
Nov-04-19 08:30AM  
Nov-02-19 01:01AM  
Oct-29-19 04:05PM  
Oct-18-19 11:01AM  
Oct-17-19 08:30AM  
Oct-03-19 08:30AM  
Sep-03-19 01:28PM  
Aug-10-19 11:17AM  
Aug-07-19 04:05PM  
Aug-01-19 04:05PM  
Jul-24-19 04:15PM  
Jul-03-19 11:14AM  
Jun-02-19 10:45AM  
May-28-19 08:30AM  
May-25-19 01:28PM  
May-16-19 08:30AM  
May-09-19 05:05PM  
04:02PM  
May-01-19 04:10PM  
Apr-26-19 03:07PM  
Mar-07-19 04:10PM  
Mar-05-19 04:15PM  
Feb-06-19 08:30AM  
Jan-30-19 08:30AM  
Jan-28-19 04:05PM  
Jan-22-19 12:05PM  
Jan-10-19 08:30AM  
Jan-08-19 08:30AM  
Dec-28-18 08:52AM  
Nov-23-18 09:03AM  
Nov-13-18 07:30AM  
Nov-12-18 08:30AM  
Nov-10-18 05:00PM  
Nov-05-18 06:31PM  
Nov-02-18 05:12AM  
Nov-01-18 04:10PM  
Oct-22-18 08:30AM  
Oct-04-18 04:15PM  
Oct-03-18 04:15PM  
07:46AM  
Sep-25-18 04:15PM  
Aug-02-18 06:45PM  
04:15PM  
Jul-31-18 04:15PM  
Jun-28-18 08:30AM  
May-30-18 04:15PM  
May-03-18 07:35PM  
04:10PM  
Apr-26-18 08:30AM  
Mar-19-18 07:40AM  
Mar-12-18 09:15AM  
Mar-08-18 09:04AM  
Mar-07-18 04:06PM  
Mar-06-18 08:30AM  
Mar-01-18 06:33PM  
04:10PM  
Feb-01-18 08:30AM  
Nov-11-17 05:45PM  
Nov-06-17 05:38AM  
Nov-02-17 04:10PM  
Oct-18-17 04:10PM  
Sep-20-17 04:10PM  
Aug-11-17 07:10PM  
Aug-05-17 01:10AM  
Aug-03-17 04:10PM  
Jul-06-17 04:10PM  
Jun-05-17 08:30AM  
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint. The company is also developing CPI-006, an anti-CD73 monoclonal antibody that inhibits the production of adenosine; an antagonist of the adenosine A2B receptor; and CPI-818, a small molecule covalent inhibitor of interleukin-2 inducible kinase. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novo Holdings A/S10% OwnerJul 08Sale5.37741,4403,985,1661,389,498Jul 09 04:35 PM
Novo Holdings A/S10% OwnerJul 07Sale5.25796,6224,183,3812,130,938Jul 09 04:35 PM
MILLER RICHARD A MDPresident and CEONov 13Buy3.0014,73644,2401,178,515Nov 14 04:14 PM
MILLER RICHARD A MDPresident and CEONov 12Buy2.902727891,163,779Nov 14 04:14 PM
MILLER RICHARD A MDPresident and CEOAug 07Buy3.542,5008,8501,163,507Aug 08 04:07 PM